首页|血清胆红素和尿酸检测对冠心病危险因素评估的应用价值

血清胆红素和尿酸检测对冠心病危险因素评估的应用价值

扫码查看
目的 分析血清胆红素和尿酸(UA)检测对冠心病的评估价值。方法 100 例行冠状动脉造影术患者,依据冠状动脉造影术结果分为研究组(冠心病,60 例)和对照组(非冠心病,40 例);研究组患者根据不同冠状动脉血管病变数目分为单支组(单支血管病变,11 例)和多支组(双支及以上血管病变,49 例),根据不同冠状动脉狭窄程度分为轻度组(狭窄程度<75%,22 例)和重度组(狭窄程度≥75%,38 例)。比较研究组和对照组血清胆红素[总胆红素(TBIL)、直接胆红素(DBIL)、间接胆红素(IBIL)]、血UA水平,研究组不同冠状动脉血管病变数目和狭窄程度患者的血清胆红素、血UA水平。结果 研究组血清TBIL(9。23±1。16)μmol/L、DBIL(0。99±0。17)μmol/L、IBIL(8。52±2。17)μmol/L低于对照组的(14。37±3。12)、(3。53±1。06)、(10。41±2。75)μmol/L,血UA(392。78±70。22)μmol/L高于对照组的(280。47±45。15)μmol/L,差异具有统计学意义(P<0。05)。多支组血清TBIL(8。02±2。35)μmol/L、DBIL(0。77±0。27)μmol/L、IBIL(7。09±1。23)μmol/L低于单支组的(10。19±2。17)、(1。26±0。29)、(9。47±1。19)μmol/L,血UA(430。99±54。18)μmol/L高于单支组的(322。89±30。21)μmol/L,差异具有统计学意义(P<0。05)。重度组血清TBIL(7。44±2。62)μmol/L、DBIL(0。69±0。22)μmol/L、IBIL(6。79±1。31)μmol/L低于轻度组的(10。53±1。86)、(1。36±0。23)、(10。95±1。27)μmol/L,血UA(491。17±73。55)μmol/L高于轻度组的(316。11±42。88)μmol/L,差异具有统计学意义(P<0。05)。结论 血清胆红素和血UA是预测、诊断冠状动脉病变的简单、方便、易普及的生化指标,对冠心病患者血清胆红素和血UA进行检测可以明确疾病严重程度,更好地控制冠心病的发生和发展,减少患者及国家的医疗消耗与支出。
The application value of serum bilirubin and uric acid detection in the assessment of coronary heart disease risk factors
Objective To analyze the evaluation value of serum bilirubin and uric acid(UA)detection in the assessment of coronary heart disease risk factors.Methods 100 patients undergoing coronary angiography were divided into a study group(coronary heart disease,60 cases)and a control group(non-coronary heart disease,40 cases)according to the results of coronary angiography.Patients in the study group were divided into single-vessel group(single vessel disease,11 cases)and multi-vessel group(double or more vessel disease,49 cases)according to the number of coronary vascular lesions.According to different degree of coronary artery stenosis,the patients were divided into mild group(stenosis<75%,22 cases)and severe group(stenosis≥75%,38 cases).The levels of serum bilirubin[total bilirubin(TBIL),direct bilirubin(DBIL),indirect bilirubin(IBIL)]and blood UA were compared between the study group and the control group,and the levels of serum bilirubin and blood UA in patients with different number of coronary vascular lesions and stenosis degree in the study group.Results The serum TBIL in the study group was(9.23±1.16)μmol/L,DBIL was(0.99±0.17)μmol/L and IBIL was(8.52±2.17)μmol/L,which were lower than those of(14.37±3.12),(3.53±1.06)and(10.41±2.75)μmol/L in the control group;the serum UA of(392.78±70.22)μmol/L in the study group was higher than that of(280.47±45.15)μmol/L in the control group;the difference was statistically significant(P<0.05).The serum TBIL in multi-vessel group was(8.02±2.35)μmol/L,DBIL was(0.77±0.27)μmol/L and IBIL was(7.09±1.23)μmol/L,which were lower than those of(10.19±2.17),(1.26±0.29)and(9.47±1.19)μmol/L in single-vessel group;the serum UA of(430.99±54.18)μmol/L in multi-vessel group was higher than that of(322.89±30.21)μmol/L in single-vessel group;the difference was statistically significant(P<0.05).The serum TBIL in severe group was(7.44±2.62)μmol/L,DBIL was(0.69±0.22)μmol/L and IBIL was(6.79±1.31)μmol/L,which were lower than those of(10.53±1.86),(1.36±0.23)and(10.95±1.27)μmol/L in mild group;the serum UA of(491.17±73.55)μmol/L in severe group was higher than that of(316.11±42.88)μmol/L in mild group;the difference was statistically significant(P<0.05).Conclusion Serum bilirubin and blood UA are simple,convenient and popular biochemical indicators for predicting and diagnosing coronary heart disease.Detection of serum bilirubin and blood UA in patients with coronary heart disease can clarify the severity of the disease,better control the occurrence and development of coronary heart disease,and reduce the medical consumption and expenditure of patients and the country.

Serum bilirubinUric acidCoronary heart diseaseEvaluation value

李健英、滕莹莹、沈郁东、林建华、陈英育、林桂华、余素美

展开 >

523690 广东省东莞市凤岗医院检验科

血清胆红素 尿酸 冠心病 评估价值

东莞市社会发展科技项目

20211800901882

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(1)
  • 22